Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation

被引:45
作者
Gando, S [1 ]
Nanzaki, S [1 ]
Morimoto, Y [1 ]
Kobayashi, S [1 ]
Kemmotsu, O [1 ]
机构
[1] Hokkaido Univ, Sch Med, Dept Anesthesiol & Intens Care, Kita Ku, Sapporo, Hokkaido 060, Japan
关键词
tissue factor; tissue factor pathway inhibitor; cardiac arrest; cardiopulmonary resuscitation;
D O I
10.1016/S0049-3848(99)00073-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated intravascular coagulation frequently occurs after global ischemia and reperfusion due to cardiac arrest. The present study was performed to demonstrate the role of tissue factor for coagulation pathway activation, as well as to investigate the precise time course of tissue factor pathway inhibitor (TFPI) during and after cardiopulmonary resuscitation (CPR), Thirty-two of out-of-hospital cardiac arrest patients were classified into two groups, those who achieved return of spontaneous circulation (ROSC) (n=13) and those without ROSC (n=19), Ten normal healthy volunteers served as control subjects. Serial levels of tissue factor and TFPI were measured during and after cardiac arrest and CPR. In patients with ROSC, cardiac arrest and CPR led to persistent increases in the levels of tissue factor that peaked 6 hours after arrival at the Emergency Department. Tissue factor levels in patients without ROSC also showed marked elevations compared to those of the control subjects. In both groups, the levels of TFPI were significantly lower than those in the control subjects. However, we could not find differences in the levels of the two markers between the patients with ROSC and those without ROSC, In conclusion, we demonstrated persistent elevation of the tissue factor levels associated with low TFPI during and after CPR in patients with out-of-hospital cardiac arrest. These results indicate the activation of the extrinsic coagulation pathway without adequate TFPI generation, which may contribute to thrombin activation and fibrin formation after whole-body ischemia and reperfusion, (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 1992, Journal of the American Medical Association, DOI [10. 1001/jama. 1992. 03490160041023, DOI 10.1001/JAMA.1992.03490160041023]
[2]   ACTIVATION OF BLOOD-COAGULATION AFTER CARDIAC-ARREST IS NOT BALANCED ADEQUATELY BY ACTIVATION OF ENDOGENOUS FIBRINOLYSIS [J].
BOTTIGER, BW ;
MOTSCH, T ;
BOHRER, H ;
BOKER, T ;
AULMANN, M ;
NAWROTH, PP ;
MARTIN, E .
CIRCULATION, 1995, 92 (09) :2572-2578
[4]  
Brozna J P, 1990, Blood Coagul Fibrinolysis, V1, P415, DOI 10.1097/00001721-199010000-00009
[5]   IN-SITU ISCHEMIA AND HYPOXIA ENHANCE ALVEOLAR MACROPHAGE TISSUE FACTOR EXPRESSION [J].
COMPEAU, CG ;
MA, J ;
DECAMPOS, KN ;
WADDELL, TK ;
BRISSEAU, GF ;
SLUTSKY, AS ;
ROTSTEIN, OD .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (04) :446-455
[6]  
CUMMINS RO, 1991, ANN EMERG MED, V20, P861
[7]   THE CLINICAL-VALUE OF TISSUE FACTOR ASSAYS [J].
FRANCIS, JL ;
CARVALHO, M ;
FRANCIS, DA .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 :S37-S44
[8]  
Gando S, 1998, THROMB HAEMOSTASIS, V79, P1111
[9]  
Gando S, 1997, THROMB HAEMOSTASIS, V77, P278
[10]   INCREASED NEUTROPHIL ELASTASE RELEASE IN PATIENTS WITH CARDIOPULMONARY ARREST - ROLE OF ELASTASE INHIBITOR [J].
GANDO, S ;
TEDO, I .
INTENSIVE CARE MEDICINE, 1995, 21 (08) :636-640